SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-036125
Filing Date
2020-08-04
Accepted
2020-08-04 16:16:58
Documents
14
Period of Report
2020-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K enta-8k_20200804.htm   iXBRL 8-K 44791
2 EX-99.1 enta-ex991_6.htm EX-99.1 318076
3 GRAPHIC g5sktpnwakeu000001.jpg GRAPHIC 3526
  Complete submission text file 0001564590-20-036125.txt   509404

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA enta-20200804.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20200804_lab.xml EX-101.LAB 18712
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20200804_pre.xml EX-101.PRE 11167
7 EXTRACTED XBRL INSTANCE DOCUMENT enta-8k_20200804_htm.xml XML 3400
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 201073519
SIC: 2834 Pharmaceutical Preparations